Predominant Distribution of the RNAi Machinery at Apical Adherens Junctions in Colonic Epithelia Is Disrupted in Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Apr 2020
Historique:
received: 10 03 2020
revised: 04 04 2020
accepted: 04 04 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 5 1 2021
Statut: epublish

Résumé

The RNA interference (RNAi) machinery is an essential component of the cell, regulating miRNA biogenesis and function. RNAi complexes were thought to localize either in the nucleus, such as the microprocessor, or in the cytoplasm, such as the RNA-induced silencing complex (RISC). We recently revealed that the core microprocessor components DROSHA and DGCR8, as well as the main components of RISC, including Ago2, also associate with the apical adherens junctions of well-differentiated cultured epithelial cells. Here, we demonstrate that the localization of the core RNAi components is specific and predominant at apical areas of cell-cell contact of human normal colon epithelial tissues and normal primary colon epithelial cells. Importantly, the apical junctional localization of RNAi proteins is disrupted or lost in human colon tumors and in poorly differentiated colon cancer cell lines, correlating with the dysregulation of the adherens junction component PLEKHA7. We show that the restoration of PLEKHA7 expression at adherens junctions of aggressively tumorigenic colon cancer cells restores the junctional localization of RNAi components and suppresses cancer cell growth in vitro and in vivo. In summary, this work identifies the apical junctional localization of the RNAi machinery as a key feature of the differentiated colonic epithelium, with a putative tumor suppressing function.

Identifiants

pubmed: 32272708
pii: ijms21072559
doi: 10.3390/ijms21072559
pmc: PMC7177752
pii:
doi:

Substances chimiques

MicroRNAs 0
RNA-Binding Proteins 0
Ribonuclease III EC 3.1.26.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Concern Foundation
ID : Conquer Cancer Now Award
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA138313
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103499
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM130457
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Organisme : Abney Foundation
ID : Scholarship Award
Organisme : College of Medicine, MUSC
ID : Digestive Diseases Pilot & Feasibility Studies Award
Organisme : NCI NIH HHS
ID : R50 CA211529
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001451
Pays : United States
Organisme : American Cancer Society
ID : IRG-16-185-17

Références

J Cell Biol. 2009 Feb 9;184(3):437-50
pubmed: 19188496
PLoS One. 2010 Oct 27;5(10):e13665
pubmed: 21060868
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Nature. 2015 May 14;521(7551):S16
pubmed: 25970454
Islets. 2009 Sep-Oct;1(2):137-47
pubmed: 21099261
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
J Exp Clin Cancer Res. 2018 Jul 11;37(1):146
pubmed: 29996940
Clin Colorectal Cancer. 2014 Mar;13(1):5-13
pubmed: 24361441
PLoS One. 2015 May 13;10(5):e0127119
pubmed: 25970424
PLoS One. 2015 Aug 13;10(8):e0135442
pubmed: 26270346
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195621
Cell Death Dis. 2017 Oct 12;8(10):e3096
pubmed: 29022915
Prog Mol Biol Transl Sci. 2013;116:409-32
pubmed: 23481205
J Biol Chem. 2001 Jul 27;276(30):28006-13
pubmed: 11382764
Nat Cell Biol. 2015 Sep;17(9):1145-57
pubmed: 26302406
Exp Cell Res. 2017 Sep 1;358(1):78-85
pubmed: 28412244
Gastroenterology. 1989 Mar;96(3):736-49
pubmed: 2914637
Nat Rev Mol Cell Biol. 2014 Jun;15(6):397-410
pubmed: 24824068
J Mol Med (Berl). 2016 Jun;94(6):629-44
pubmed: 27094812
Int J Oncol. 2018 Nov;53(5):1939-1952
pubmed: 30226594
Front Med (Lausanne). 2014 Aug 25;1:24
pubmed: 25593900
J Pathol. 2014 Mar;232(4):415-27
pubmed: 24293274
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Nucleic Acids Res. 2016 Jun 20;44(11):5330-43
pubmed: 27185895
PLoS One. 2010 Aug 20;5(8):e12207
pubmed: 20808826
Nucleic Acids Res. 2016 Dec 1;44(21):10454-10466
pubmed: 27471035
Nat Rev Cancer. 2008 Jun;8(6):415-24
pubmed: 18480839
J Cell Sci. 2001 Feb;114(Pt 3):503-12
pubmed: 11171320
Clin Cancer Res. 2014 May 15;20(10):2631-42
pubmed: 24658157
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Biochem Biophys Res Commun. 2012 Jan 20;417(3):1100-5
pubmed: 22227196
Oncol Rep. 2019 Nov;42(5):1825-1832
pubmed: 31545460
J Cell Biol. 2017 Oct 2;216(10):3073-3085
pubmed: 28877994
J Cell Biochem. 2018 Jul;119(7):6288-6295
pubmed: 29663476
Nat Rev Genet. 2010 Sep;11(9):597-610
pubmed: 20661255
Am J Physiol. 1984 Sep;247(3 Pt 1):C260-7
pubmed: 6476109
J Cell Biol. 2014 Mar 3;204(5):839-56
pubmed: 24590176
J Cell Sci. 2004 Apr 1;117(Pt 9):1675-85
pubmed: 15075229
Cell Biol Toxicol. 2005 Jan;21(1):1-26
pubmed: 15868485
Int J Mol Sci. 2019 Sep 10;20(18):
pubmed: 31510013
Nat Rev Mol Cell Biol. 2010 Jul;11(7):502-14
pubmed: 20571587
Nat Rev Genet. 2013 Jul;14(7):447-59
pubmed: 23732335
Cell. 2008 Nov 28;135(5):948-59
pubmed: 19041755
Nat Cell Biol. 2020 Jan;22(1):97-107
pubmed: 31907411
PLoS Genet. 2011 Aug;7(8):e1002218
pubmed: 21876675
Nature. 2019 Sep;573(7774):439-444
pubmed: 31485072
J Cell Biol. 2006 May 8;173(3):431-41
pubmed: 16682529
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Curr Opin Cell Biol. 2018 Oct;54:30-36
pubmed: 29587176
Cell Cycle. 2016;15(4):498-505
pubmed: 26822694
Biochim Biophys Acta. 2012 Aug;1826(1):23-31
pubmed: 22440943
Arch Biochem Biophys. 2012 Aug 1;524(1):43-7
pubmed: 22085498
Biochem J. 2014 May 15;460(1):117-25
pubmed: 24593661
Dev Cell. 2017 Nov 20;43(4):418-435.e13
pubmed: 29161592
J Gastrointest Cancer. 2018 Mar;49(1):102-103
pubmed: 29218654
J Invest Dermatol. 2018 Apr;138(4):882-892
pubmed: 29104160
J Surg Res. 2008 Jun 15;147(2):276-81
pubmed: 17961596
World J Gastroenterol. 2016 Mar 21;22(11):3117-26
pubmed: 27003989
Gut. 2013 Sep;62(9):1315-26
pubmed: 22735571
Nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):306-7
pubmed: 18477987

Auteurs

Joyce Nair-Menon (J)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Amanda C Daulagala (AC)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Dean M Connor (DM)

Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Lauren Rutledge (L)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Trevor Penix (T)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Mary Catherine Bridges (MC)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Bridgette Wellslager (B)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Demetri D Spyropoulos (DD)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Cynthia D Timmers (CD)

Department of Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Ann-Marie Broome (AM)

Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Antonis Kourtidis (A)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH